Impact of COVID-19 pandemic on routine immunization

Ann Med. 2021 Dec;53(1):2286-2297. doi: 10.1080/07853890.2021.2009128.ABSTRACTThe current COVID-19 global pandemic continues to impact healthcare services beyond those directly related to the management of SARS-CoV-2 transmission and disease. We reviewed the published literature to assess the pandemic impact on existing global immunization activities and how the impact may be addressed. Widespread global disruption in routine childhood immunization has impacted a majority of regions and countries, especially in the initial pandemic phases. While data indicate subsequent recovery in immunization rates, a substantial number of vulnerable people remain unvaccinated. The downstream impact may be even greater in resource-limited settings and economically poorer populations, and consequently there are growing concerns around the resurgence of vaccine-preventable diseases, particularly measles. Guidance on how to address immunization deficits are available and continue to evolve, emphasizing the importance of maintaining and restoring routine immunization and necessary mass vaccination campaigns during and after pandemics. In this, collaboration between a broad range of stakeholders (governments, industry, healthcare decision-makers and frontline healthcare professionals) and clear communication and engagement with the public can help achieve these goals.Key messagesThe COVID-19 pandemic has a substantial impact on essential immunization activities.Disruption to mass vaccination cam...
Source: Annals of Medicine - Category: Internal Medicine Authors: Source Type: research

Related Links:

Guillain–Barre syndrome (GBS), the most frequent cause of acute paralytic neuropathy, is an inflammatory polyneuropathy that is autoimmune in nature. Many infectious agents such as Campylobacter jejuni (the most commonly identified bacteria associated with GBS), cytomegalovirus, Epstein–Barr virus, measles virus, influenza A virus, and Mycoplasma pneumonia, as well as enterovirus D68 and Zika virus and noninfectious agents such as vaccines and surgeries have been reported to trigger GBS. Three main variants of GBS include the classic acute inflammatory demyelinating polyneuropathy (AIDP), which is the most comm...
Source: Reviews in Medical Microbiology - Category: Microbiology Tags: FOCUS ON COVID-19 Source Type: research
Due to the social isolation measures adopted in an attempt to mitigate the risk of transmission of SARS-CoV-2, there has been a reduction in vaccination coverage of children and adolescents in several countrie...
Source: BMC Infectious Diseases - Category: Infectious Diseases Authors: Tags: Research Source Type: research
ConclusionsDuring the COVID-19 outbreak in 2020 there was a decline in all notified infectious diseases compared to the previous years, likely due to massive NPIs adoption, as well as, possibly, to decreased access to care and preventive services that caused difficulties to the surveillance system to detect notifiable infectious diseases. VCRs were still high for most important vaccines while there was a decline for other vaccines as evidence of the impact of the pandemic on vaccination activities.Key messagesNPIs had a deep impact on the reduction of airborne diseases.The decline for non-airborne infections is likely due ...
Source: The European Journal of Public Health - Category: General Medicine Source Type: research
One Monday in late February 2020, Lauren Gardner was working frantically. The website she’d been managing around the clock for the last month—which tracked cases of an emerging respiratory disease called COVID-19, and presented the spread in maps and charts—was, all of a sudden, getting inundated with visitors and kept crashing. As Gardner, an associate professor of engineering at Johns Hopkins University (JHU), struggled to get the site online again, an official in the Trump Administration falsely claimed on Twitter that JHU had deliberately censored the information. “Seems like bad timing to sto...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Getting the kids ready to go back to school each fall is stressful enough in a normal year, never mind in the midst of a pandemic. Between the more transmissible Delta coronavirus variant, rising cases across the country and new masking guidance from the U.S. Centers for Disease Control and Prevention (CDC), there’s a lot for parents to navigate as they plan for schools to reopen this August and September. On the whole, experts seem to agree it’s time to get kids back into their classrooms. Remote learning set many children—especially students of color—back academically, cut them off from essential ...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
The current pandemic of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) highlights an urgent need to develop a safe, efficacious, and durable vaccine. Using a measles virus (rMeV) vaccine strain as the backbone, we developed a series of recombinant attenuated vaccine candidates expressing various forms of the...
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Tags: Microbiology, Coronavirus (COVID-19) Biological Sciences Source Type: research
2021 got off to a grim pandemic start in the U.S. A huge surge in COVID-19 cases followed the holiday season, peaking at around 300,000 new cases on Jan. 8, 2020. More than 20,000 Americans lost their lives to the virus in a single week in January alone and over 146,00 in total have died since the start of the year. But six weeks later, the picture looks more promising. New daily cases have fallen sharply, daily deaths have fallen to levels not seen since Thanksgiving, and the pace of vaccine roll-out is speeding up. These positive trends mean that we can now begin to ask what the endgame might look like. Would we be happy...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
m Vaccine development against SARS-CoV-2 has been fierce due to the devastating COVID-19 pandemic and has included all potential approaches for providing the global community with safe and efficient vaccine candidates in the shortest possible timeframe. Viral vectors have played a central role especially using adenovirus-based vectors. Additionally, other viral vectors based on vaccinia viruses, measles viruses, rhabdoviruses, influenza viruses and lentiviruses have been subjected to vaccine development. Self-amplifying RNA virus vectors have been utilized for lipid nanoparticle-based delivery of RNA as COVID-19 vaccin...
Source: Viruses - Category: Virology Authors: Tags: Review Source Type: research
o In the race for a vaccine against SARS-CoV-2, the synthetic mRNA format has been shown to be the fastest one and proved to be safe and highly efficient, even at the very low dose of a few µg per injection. The mRNA vaccines are not new: vaccines that are based on attenuated mRNA viruses, such as Mumps, Measles, and Rubella, immunize by delivering their mRNAs into the cells of the vaccinated individual, who produces the viral proteins that then prime the immune response. Synthetic mRNA in liposomes can be seen as a modern, more refined, and thereby a safer version of those live attenuated RNA viruses. The anti-C...
Source: Viruses - Category: Virology Authors: Tags: Review Source Type: research
When does a pandemic end? Is it when life regains a semblance of normality? Is it when the world reaches herd immunity, the benchmark at which enough people are immune to an infectious disease to stop its widespread circulation? Or is it when the disease is defeated, the last patient cured and the pathogen retired to the history books? The last scenario, in the case of COVID-19, is likely a ways off, if it ever arrives. The virus has infected more than 100 million people worldwide and killed more than 2 million. New viral variants even more contagious than those that started the pandemic are spreading across the world. And...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Cover Story COVID-19 feature Magazine Source Type: news
More News: COVID-19 | Internal Medicine | Measles | Measles Vaccine | Pandemics | SARS | Vaccines